Oscar Health (NYSE:OSCR) Given "Neutral" Rating at Robert W. Baird

Key Points

• Oscar Health's stock has been given a "neutral" rating by Robert W. Baird, with a revised target price of $14.00, indicating a potential downside of 1.53% from its last close.
• The company has faced multiple downgrades from various analysts, with a consensus rating of "Reduce"** and an average target price of $12.21.
• Oscar Health reported a quarterly revenue of $3 billion, exceeding analyst expectations, and a year-on-year revenue increase of 42.2% despite a slight decline in stock price to $14.22.

Oscar Health (NYSE:OSCR - Get Free Report)'s stock had its "neutral" rating reaffirmed by equities researchers at Robert W. Baird in a note issued to investors on Friday,Benzinga reports. They presently have a $14.00 target price on the stock, down from their previous target price of $28.00. Robert W. Baird's target price indicates a potential downside of 1.53% from the company's previous close.

Other equities research analysts also recently issued reports about the stock. Wall Street Zen downgraded shares of Oscar Health from a "buy" rating to a "hold" rating in a research report on Sunday, June 8th. UBS Group reaffirmed a "sell" rating and issued a $11.00 price objective (down from $15.00) on shares of Oscar Health in a research report on Tuesday, July 15th. Piper Sandler downgraded shares of Oscar Health from an "overweight" rating to a "neutral" rating and set a $14.00 price objective for the company. in a research report on Monday, July 14th. Raymond James Financial downgraded shares of Oscar Health from an "outperform" rating to a "market perform" rating in a research report on Tuesday, June 24th. Finally, Barclays reduced their target price on shares of Oscar Health from $17.00 to $11.00 and set an "underweight" rating for the company in a research report on Wednesday. Five analysts have rated the stock with a sell rating and four have assigned a hold rating to the company. Based on data from MarketBeat, Oscar Health currently has a consensus rating of "Reduce" and an average target price of $12.21.

Oscar Health Trading Down 10.4%

NYSE:OSCR opened at $14.22 on Friday. The company has a debt-to-equity ratio of 0.22, a current ratio of 0.88 and a quick ratio of 0.88. The firm has a 50-day moving average of $16.05 and a 200-day moving average of $14.92. The company has a market cap of $3.62 billion, a PE ratio of 50.78 and a beta of 1.90. Oscar Health has a one year low of $11.20 and a one year high of $23.79.

Oscar Health (NYSE:OSCR - Get Free Report) last issued its quarterly earnings data on Wednesday, May 7th. The company reported $0.92 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.83 by $0.09. Oscar Health had a net margin of 1.22% and a return on equity of 10.59%. The business had revenue of $3 billion during the quarter, compared to the consensus estimate of $2.87 billion. During the same period in the prior year, the firm posted $0.62 EPS. The firm's quarterly revenue was up 42.2% compared to the same quarter last year. As a group, equities research analysts expect that Oscar Health will post 0.69 EPS for the current fiscal year.

Insider Buying and Selling at Oscar Health

In other news, Director Elbert O. Jr. Robinson sold 25,000 shares of the stock in a transaction that occurred on Monday, May 12th. The shares were sold at an average price of $16.43, for a total transaction of $410,750.00. Following the completion of the transaction, the director directly owned 64,512 shares of the company's stock, valued at $1,059,932.16. This represents a 27.93% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 24.39% of the stock is owned by corporate insiders.

Institutional Trading of Oscar Health

A number of institutional investors have recently modified their holdings of the business. Hsbc Holdings PLC lifted its stake in shares of Oscar Health by 2.7% during the 1st quarter. Hsbc Holdings PLC now owns 24,113 shares of the company's stock valued at $313,000 after buying an additional 632 shares in the last quarter. Tempus Wealth Planning LLC lifted its stake in Oscar Health by 6.7% in the 1st quarter. Tempus Wealth Planning LLC now owns 14,392 shares of the company's stock worth $189,000 after purchasing an additional 906 shares in the last quarter. Focus Partners Wealth lifted its stake in Oscar Health by 1.8% in the 1st quarter. Focus Partners Wealth now owns 55,158 shares of the company's stock worth $723,000 after purchasing an additional 949 shares in the last quarter. Xponance Inc. lifted its stake in Oscar Health by 7.1% in the 1st quarter. Xponance Inc. now owns 15,423 shares of the company's stock worth $202,000 after purchasing an additional 1,029 shares in the last quarter. Finally, CWM LLC lifted its stake in Oscar Health by 50.7% in the 1st quarter. CWM LLC now owns 3,204 shares of the company's stock worth $42,000 after purchasing an additional 1,078 shares in the last quarter. 75.70% of the stock is currently owned by hedge funds and other institutional investors.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.